Equity Research, Broker Reports, and media content on SUMMIT THERAPEUTICS PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about SUMMIT THERAPEUTICS PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on SUMMIT THERAPEUTICS PLC. We currently have 83 research reports from 1 professional analysts.

Open
190
Volume
0.0m
Range
189/192
Market Cap
118m
52 Week
91.0/252
Date Source Announcement
02Feb17 12:00 GNW Summit Therapeutics to Participate in February Investor Conferences
01Feb17 12:00 GNW Summit Outline Phase 3 Programme for Novel CDI Antibiotic Ridinilazole
25Jan17 12:45 GNW Summit Therapeutics plc : Holding(s) in Company
19Jan17 16:11 GNW Summit Therapeutics plc : Exercise of Options
18Jan17 12:00 GNW Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & Development
15Dec16 12:00 GNW Summit Therapeutics plc : 3rd Quarter Results
13Dec16 15:00 GNW Summit Therapeutics plc : Notice of Results
  • Frequency of research reports

     

  • Research reports on

    SUMMIT THERAPEUTICS PLC

  • Providers covering

    SUMMIT THERAPEUTICS PLC

Latest Content

View the latest research, videos, and podcasts for this company.